FilingSEC EDGAR6-K
Galmed Pharmaceuticals Adjourns Annual General Meeting
· SEC accepted
StageShareholder Meeting
Filing content
The company adjourned its annual general meeting scheduled for September 2, 2026, to September 3, 2026, due to a lack of quorum.
AI summary of the filing. Please also check the source.Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…